NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF). Shareholders who purchased shares of WOOF during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/petco-loss-submission-form/?id=162512&from=3 CLASS PERIOD: ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Sarepta Therapeutics, Inc. regarding a class action lawsuit related to misleading statements about the safety and efficacy of its gene therapy product, ELEVIDYS [1][3]. Summary by Relevant Sections Class Action Details - The class period for the lawsuit is from June 22, 2023, to June 24, 2025 [3]. - Shareholders who purchased shares during this period are encouraged to contact the firm for potential lead plaintiff appointment, although this is not required for recovery [1][4]. Allegations Against Sarepta Therapeutics - The complaint alleges that Sarepta Therapeutics made materially false and/or misleading statements regarding ELEVIDYS, a gene therapy for Duchenne muscular dystrophy [3]. - Specific allegations include: - ELEVIDYS poses significant safety risks to patients [3]. - The trial protocols failed to detect severe side effects [3]. - Adverse events from ELEVIDYS treatment could lead to halting recruitment and dosing in trials, attracting regulatory scrutiny [3]. - The misleading statements resulted in a lack of reasonable basis for the company's positive outlook on the therapy [3]. Next Steps for Shareholders - Shareholders are advised to register for the class action by August 25, 2025, to participate in the case [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software [4]. About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].

LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or "the Company") (NASDAQ: TLX) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Telix disclosed on July 22, 2025, that it had received a subpoena from ...

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations related to the proposed acquisition of NorthWestern Energy by Black Hills Corp, which will result in NorthWestern Energy stockholders receiving 0.98 shares of Black Hills common stock for each share they hold [1] Group 1 - The acquisition is expected to close in the latter half of 2026 [1] - NorthWestern Energy stockholders are projected to own approximately 44% of the combined company post-acquisition [1]

Core Viewpoint - A class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. for alleged violations of securities laws, specifically related to misleading statements about the efficacy of its lung cancer treatment, poziotinib [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from March 17, 2022, to September 22, 2022, with a deadline for lead plaintiff appointments set for September 24, 2025 [2]. - The complaint alleges that Spectrum made false and misleading statements regarding the results of its Pinnacle Study for poziotinib, which were less favorable than presented to investors [2]. Group 2: Shareholder Participation - Shareholders who purchased SPPI shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although this is not a requirement for recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress at no cost [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4]. - The firm represents large hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [4].

Core Viewpoint - The Schall Law Firm is investigating Fortinet, Inc. for potential violations of securities laws, particularly regarding misleading statements and undisclosed information that may have affected investors [1][2]. Group 1: Investigation Details - The investigation centers on whether Fortinet issued false or misleading statements and failed to disclose critical information to investors [2]. - Fortinet's Q2 financial results, reported on August 6, 2025, have raised concerns among investors, particularly regarding the company's statement that 40% to 50% of its accelerated firewall refresh, estimated at $450 million and 650,000 units, was completed [2]. - Following the Q2 results and the confusion surrounding product revenue growth, Fortinet's shares dropped by 25.3% on August 7, 2025 [2].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Petco Health and Wellness Company, Inc. regarding a class action lawsuit related to misleading statements made by the company during the class period from January 14, 2021, to June 5, 2025 [3]. Group 1: Allegations Against Petco - Allegations include that Petco's pandemic-related growth was not sustainable and that its business model focused on premium pet food was overstated [3]. - The strength of Petco's differentiated product strategy was claimed to be exaggerated, and the company downplayed the severity of issues affecting its business [3]. - Defendants allegedly overstated Petco's ability to achieve sustainable, profitable growth, leading to materially false and misleading public statements [3]. Group 2: Class Action Details - The deadline for shareholders to register for the class action is August 29, 2025, and participation does not incur any cost or obligation [4]. - Shareholders who register will receive updates through a portfolio monitoring software regarding the status of the case [4]. - The Gross Law Firm aims to protect investors' rights and seeks recovery for losses incurred due to misleading statements by the company [5].

NEW YORK, Aug. 5, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by HilleVax, Inc. (NASDAQ: HLVX) and its board of directors concerning the proposed acquisition of the company by XOMA Royalty Corporation (NASDAQ: XOMA). Stockholders will receive $1.95 in cash and one contingent value right for each share of HilleVax stock that they hold. The transaction is expected to close in September 2025.If you are a stockholder of HilleVax, Inc. and are interested in obtaining ...

NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO). Shareholders who purchased shares of ANRO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/alto-neuroscience-inc-loss-submission-form/?id=159235&from=3 CLASS PERIOD: T ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Vestis Corporation regarding a class action lawsuit due to allegations of misleading statements and failure to meet growth expectations [1][3]. Summary by Relevant Sections Allegations - The complaint alleges that Vestis Corporation provided overly positive statements while concealing material adverse facts about its business growth capabilities. Specifically, it was claimed that Vestis would struggle to execute strategic initiatives aimed at improving customer experience and driving new customer growth [3]. Financial Performance - On May 7, 2025, Vestis announced disappointing financial results for Q2 of fiscal 2025, withdrawing its revenue and growth guidance for the full fiscal year. The company reported a significant decline in stock price, dropping from $8.71 per share on May 6, 2025, to $5.44 per share on May 7, 2025, marking a decline of approximately 37.54% in one day [3]. Class Action Details - The class period for the lawsuit is defined as May 2, 2024, to May 6, 2025. Shareholders are encouraged to register for participation in the class action, with a deadline set for August 8, 2025. Registration allows shareholders to receive updates on the case [3][4]. Law Firm's Commitment - The Gross Law Firm emphasizes its mission to protect investors' rights against deceit and fraud, seeking recovery for those who suffered losses due to misleading statements that inflated stock prices [5].